These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1663995)

  • 1. Effects of vancomycin, teicoplanin, daptomycin and coumermycin on normal immune capabilities.
    Tawfik AF
    J Chemother; 1991 Aug; 3(4):226-31. PubMed ID: 1663995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro interactions of carumonam in combination with coumermycin, teicoplanin, flucloxacillin and vancomycin.
    Machka K; Milatovic D; Braveny I
    Chemioterapia; 1987 Jun; 6(2 Suppl):117-8. PubMed ID: 2978385
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocci.
    Machka K; Braveny I
    Eur J Clin Microbiol; 1987 Feb; 6(1):96-9. PubMed ID: 3032613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and ciprofloxacin, alone and in combination with rifampicin or LM 427, against Staphylococcus aureus.
    Van der Auwera P; Joly P
    J Antimicrob Chemother; 1987 Mar; 19(3):313-20. PubMed ID: 3032884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of teicoplanin and vancomycin disk susceptibility tests.
    Barry AL; Thornsberry C; Jones RN
    J Clin Microbiol; 1986 Jan; 23(1):100-3. PubMed ID: 2939101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bactericidal effect of daptomycin (LY 146032) compared with vancomycine and teicoplanin against gram-positive bacteria].
    Caillon J; Juvin ME; Pirault JL; Drugeon HB
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):540-8. PubMed ID: 2552378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of vancomycin and teicoplanin against human polymorphonuclear leucocytes: a comparative study.
    Morán FJ; Puente LF; Pérez-Giraldo C; Blanco MT; Hurtado C; Gómez-García AC
    J Antimicrob Chemother; 1991 Sep; 28(3):415-8. PubMed ID: 1835722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile.
    Bartoloni A; Colao MG; Orsi A; Dei R; Giganti E; Parenti F
    J Antimicrob Chemother; 1990 Nov; 26(5):627-33. PubMed ID: 1688341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of mersacidin, a novel peptide, compared with that of vancomycin, teicoplanin, and daptomycin.
    Niu WW; Neu HC
    Antimicrob Agents Chemother; 1991 May; 35(5):998-1000. PubMed ID: 1649577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of various antibiotics on phagocytosis of Staphylococcus aureus by human polymorphonuclear leucocytes.
    Van der Auwera P; Husson M; Frühling J
    J Antimicrob Chemother; 1987 Sep; 20(3):399-404. PubMed ID: 3680077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro effects of teicoplanin, teicoplanin derivative MDL 62211 and vancomycin on human polymorphonuclear cell function.
    Capodicasa E; Scaringi L; Rosati E; De Bellis F; Sbaraglia G; Marconi P; Del Favero A
    J Antimicrob Chemother; 1991 May; 27(5):619-26. PubMed ID: 1832144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activity of LY146032 (daptomycin), a new lipopeptide antimicrobial.
    Hodinka RL; Jack-Wait K; Wannamaker N; Walden TP; Gilligan PH
    Eur J Clin Microbiol; 1987 Feb; 6(1):100-3. PubMed ID: 3032607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of teicoplanin on leukocytic activity and intraleukocytic micro-organisms.
    Fietta A; Bersani C; De Rose V; Grassi FM; Gialdroni Grassi G
    J Hosp Infect; 1986 Mar; 7 Suppl A():57-63. PubMed ID: 2871098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates to vancomycin, teicoplanin, linezolide and daptomycin].
    Celikbilek N; Ozdem B; Gürelik FC; Güvenman S; Güner HR; Açıkgöz ZC
    Mikrobiyol Bul; 2011 Jul; 45(3):512-8. PubMed ID: 21935784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of daptomycin in comparison to glycopeptides and other antimicrobials when tested against numerous species of coagulase-negative Staphylococcus.
    Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):212-4. PubMed ID: 22608137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research into biocompatibility and cytotoxicity of daptomycin, gentamicin, vancomycin and teicoplanin antibiotics at common doses added to bone cement.
    Kılınç S; Tunç T; Pazarcı Ö; Sümer Z
    Jt Dis Relat Surg; 2020; 31(2):328-334. PubMed ID: 32584733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of human monocytes on the antibacterial activity of vancomycin and teicoplanin against Staphylococcus aureus.
    van der Broek PJ; Buys LF
    J Antimicrob Chemother; 1990 May; 25(5):787-95. PubMed ID: 2142684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of the new glycopeptide decaplanin.
    Neu HC; Chin NX; Niu WW
    Eur J Clin Microbiol Infect Dis; 1992 May; 11(5):458-62. PubMed ID: 1330562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin.
    Pohlod DJ; Saravolatz LD; Somerville MM
    J Antimicrob Chemother; 1987 Aug; 20(2):197-202. PubMed ID: 2822646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative antibacterial effects of daptomycin, vancomycin and teicoplanin studied in an in vitro pharmacokinetic model of infection.
    Bowker KE; Noel AR; MacGowan AP
    J Antimicrob Chemother; 2009 Nov; 64(5):1044-51. PubMed ID: 19759041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.